Kieran James Crowley

Title: Kieran James Crowley: Innovator in Cancer Treatment and Pharmaceutical Formulation

Introduction

Kieran James Crowley is a notable inventor based in Highland Park, NJ (US). He has made significant contributions to the field of cancer treatment and pharmaceutical formulation, holding two patents that showcase his innovative approach to medical challenges.

Latest Patents

One of Crowley's latest patents focuses on methods for treating cancer. This invention relates to treating patients with advanced forms of cancer, such as clear cell renal cell carcinoma, by administering X4P-001 to reduce angiogenic escape that typically occurs with TKI therapy. The methods demonstrate surprising results, including regression of tumor size and cell number, with comparatively little toxicity. His second patent involves an oral solid dosage form containing nanoparticles. This formulation is created by reducing the particle size of at least one pharmaceutically active ingredient dispersed in a solution containing fish gelatin to form a nanosuspension, which is then freeze-dried to create the final oral solid dosage form.

Career Highlights

Throughout his career, Kieran has worked with reputable companies, including R.P. Scherer Technologies, Inc. and X4 Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in pharmaceutical technologies and cancer therapies.

Collaborations

Kieran has collaborated with notable professionals in his field, including Deepak Bahl and Danny Yu. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in cancer treatment.

Conclusion

Kieran James Crowley is a distinguished inventor whose work in cancer treatment and pharmaceutical formulation has the potential to make a significant impact on patient care. His innovative patents reflect his commitment to advancing medical science and improving treatment outcomes.